61. GENE THERAPY, The State Of The Art Dr. Abdel Aziz El Bayoumi Professor of Genetics. Dr. Khalid Al Ali Lecturer of Genetics. Department of Biological Sciences University of Qatar, Doha http://www.isesco.org.ma/pub/Eng/Gene_therapy/genether.htm

62. MMIA Gene Therapy. The link below contains an HTML version of the Microsoft PowerPoint used during the MMIA conference. Gene Therapy.htm. http://www.iupui.edu/~wellsctr/MMIA/htm/gene_therapy.htm

Gene Therapy The link below contains an HTML version of the Microsoft PowerPoint used during the MMIA conference. Gene Therapy.htm

63. PHG Foundation - Search PHG Foundation www.phgfoundation.org. Home About Contact Our Work News Events Resources What s New. Search http://www.phgfoundation.org/search/?dataSearchTypeList=news&dataSearchKeywordLi

64. The Program In Biomedical Sciences (PIBS) - Gene Therapy The Program in Biomedical Sciences (PIBS) at the University of Michigan coordinates admissions and the first year of graduate studies for thirteen Ph.D. http://www.med.umich.edu/pibs/faculty/gene_therapy.htm

Prospective Students Current Students Apply To PIBS Request Information ... Core Technology Alliance Search this site: Search Help Gene Therapy Please note: Words in italics are the official PIBS affiliations of the indicated faculty. James R. Baker Jr., MD Determining why autoantigens are recognized in autoimmune disease; epitope mapping thyroid autoantigens from patients with autoimmune thyroid disease. Immunology. Molecular and Cellular Pathology. Kate F. Barald, Ph.D. Developmental neurobiology; molecular neurobiology studies of developing neuronal cells and synapses; gene expression in the neural crest; molecular studies of inner ear development. D. Keith Bishop, Ph.D. Cellular immunology of transplant rejection and acceptance. Sally A. Camper, Ph.D. Developmental genetics of the neuroendocrine system; transgenic mice; gene targeting; pituitary dwarfism. Kathleen Collins, M.D., Ph.D.

65. Gene Therapy Graduate Schools, Graduate Program Gene Therapy , Masters Gene Ther Directory of Gene Therapy graduate and postgraduate school programs, including contact information, program descriptions and links to leading programs http://www.gradschools.com/programs/gene_therapy.html

GradSchools.com INFO CENTER Visit our Info Center and find out everything you need to know about graduate school. From applying to studying to financial aid, our Info Center has articles, blogs, and many more resources. GradSchools.com Home Search for Graduate Programs Information Center Grad School Event Calendar ... Advertising Info Grad School Loans Select: Stafford Loan amount: Loan needed: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Graduation: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Email: GENE THERAPY Graduate School Programs - Master's, Ph.D. Programs in the United States Distance / Online Programs Certificate Programs Or select other related directories here Genetics Programs About the field of Gene Therapy: Gene therapy is the application of genetics to the therapeutic treatment of diseases and inherited abnormalities. Students will use targeted modification of gene expression and be prepared to administer genetic therapies. The major involves the study of medical genetics, genome analysis and the pharmacology of gene transfer. Genetic screening, bioethics and vector production are other important elements of gene therapy. This exciting field can lead graduates to careers as genetic engineers, geneticists, gene therapists, vector production managers and more. Home Search for Graduate Programs Graduate School Information Center Add or Update Programs ... Contact Us Visit our friends for: Online Degrees Online Degree Programs var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));

66. Blood -- Collected Resources : Gene Therapy Blood online. Home About Blood Authors Subscriptions Permission Advertising Public Access contact us. Institution Google Indexer Sign In http://bloodjournal.hematologylibrary.org/cgi/collection/gene_therapy

window.onload=preloadImages; SEARCH: Advanced Gene Therapy Citations 1-10 of 384 total displayed. Most recent content (1 Apr 2008): Neutrophil-selective CD18 silencing using RNA interference in vivo Xavier Cullere, Michael Lauterbach, Naotake Tsuboi, and Tanya N. Mayadas Blood 2008; 111: 3591-3598. [Abstract] [Full text] [PDF] Past content (since Aug 1998): An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activation Byoung Y. Ryu, Marguerite V. Evans-Galea, John T. Gray, David M. Bodine, Derek A. Persons, and Arthur W. Nienhuis Blood 2008; 111: 1866-1875. [Abstract] [Full text] [PDF] Leszek Lisowski and Michel Sadelain Blood 2007; 110: 4175-4178. [Abstract] [Full text] [PDF] Deletions within the HSV-tk transgene in long-lasting circulating gene-modified T cells infused with a hematopoietic graft Blood 2007; 110: 3842-3852. [Abstract] [Full text] [PDF] Selecting highly affine and well-expressed TCRs for gene therapy of melanoma Annelies Jorritsma, Raquel Gomez-Eerland, Maarten Dokter, Willeke van de Kasteele, Yvonne M. Zoet, Ilias I. N. Doxiadis, Nathalie Rufer, Pedro Romero, Richard A. Morgan, Ton N. M. Schumacher, and John B. A. G. Haanen

67. Charles River - Biopharmaceutical Services: Gene Therapy Analytical Chemistry and Custom Assay Validation Cell Characterization Human and Specific Viruses Molecular Testing and DNA Detection. Resources http://www.criver.com/biopharmaceutical_services/product_programs/gene_therapy.h

Biopharmaceutical Services Biopharmaceutical Services Product Programs Cell Therapy Gene Therapy ... Agrochemical and Veterinary Gene Therapy The replacement of a person's faulty genetic material with normal genetic material, known as gene therapy, may offer innovative solutions to treat or cure a disease or abnormal medical condition. A significant safety concern is the potential presence of Replication Competent Retrovirus (RCR) and Replication Competent Adenovirus (RCA) in retroviral or adenoviral vector-based gene therapy products, respectively. RCR and RCA may develop at any step during the manufacturing process of gene therapy products. To ensure the safety of these therapies, the FDA has issued guidelines that encompass: Cell Line Development Cell Banking Services Cell Storage Services Cell Line Characterization ... Release Testing What's New All news items To submit a question click ASK CHARLES RIVER or call 1-877-CRIVER1. Charles River Home Careers Humane Care Events ... Contact

68. Genetics & Genomics/Gene Therapy Protocols Protocols. A Simplified System for Rapid Generation of Recombinant Adenoviruses ( ) Give detailed guide to the construction of recombinant adenoviruses. http://www.protocol-online.org/prot/Genetics___Genomics/Gene_Therapy/

BioBlog PubAlert BioTool BioProduct ... Home Search Protocols: All Category This Category Advanced Search Top : Gene Therapy Subcategories Gene Delivery Protocols A Simplified System for Rapid Generation of Recombinant Adenoviruses Give detailed guide to the construction of recombinant adenoviruses. http://www.coloncancer.org/adeasy.htm Added: Tue May 14 2002, Hits: 1310, Reviews: Write review Cached Coating complexes with pHPMA (Gene Delivery Group, University of Birmingham) http://web.bham.ac.uk/can4psd4/brum/coating.html Added: Wed Sep 04 2002, Hits: 116, Reviews: Write review Cached Ethidium Bromide assay for DNA complex formation (Gene Delivery Group, University of Birmingham) http://web.bham.ac.uk/can4psd4/brum/etbr.html Added: Wed Sep 04 2002, Hits: 218, Reviews: Write review Cached Gel Retardation assay for complex formation (Gene Delivery Group, University of Birmingham) The condensation of DNA by cationic polymers can be measured by a reduction of the mobility of DNA on agarose that leads to the retention of DNA in the wells http://web.bham.ac.uk/can4psd4/brum/agargel.html

69. Gene Therapy | Geneforum Topics. Bioweapons Gene Therapy Genetically Modified Organisms (GMOs) Genetic Enhancement/Gene Doping Genetic Privacy Genetics and Pop Culture Genetic http://www.geneforum.org/topics/gene_therapy

@import "/misc/drupal.css"; @import "/modules/tagadelic/tagadelic.css"; @import "/sites/www.geneforum.org/themes/geneforum/style.css"; About Us Genetizen Blog Gene Forums Your Stories User login Username: Password: Create new account Request new password Topics Bioweapons Gene Therapy Genetically Modified Organisms (GMOs) Genetic Enhancement/Gene Doping ... Stem Cells Syndicate Home Gene Therapy How to find specific blog entries Bioweapons Gene Therapy Genetic Enhancement/Gene Doping ... login or register to post comments Jolee Mohr took part in a gene therapy clinical trialand died According to Wikipedia, "death is the permanent end of the life of a biological organism." My younger daughter would consider that a "scientific" definitionlacking humaness and empathy. This approach was also the approach I viewed this morning. Today's review of the death last July of a young woman participating in a gene therapy trial was webcast and I did manage to get up at 5:00 am to watch all 7 hours of the live video. The meeting and review of gene therapy trials in general and this particular death were definitely "scientific". Even though I am familiar with much of the language of clinical trials, I had trouble following many of the details of the specific gene therapy and rheumatoid arthritis. If anyone doubted that the presentations were factual and unemotional, you only needed to hear the first and last sentence spoken by the victim's husband to get back to reality: Gene Therapy Blog Entry read more login or

70. Gene Therapy | Gene Therapy News, Research And Current Events Brightsurf Gene therapy news and Gene therapy current events, research and discoveries. http://www.brightsurf.com/search/r-a/Gene_therapy/1/Gene_therapy_news.html

Brightsurf Science News The latest science news and science current events. Top Science News The top science news articles and science current events news from the past week. Add Brightsurf Science News to your Web Site Science Resources Earth Science Space Science Life Science Fields of Scientific Study ... Nanotechnology Articles Science RSS News Feeds Earth, Life and Space Science RSS News Feeds. Earth Science RSS News Space Science RSS News Life Science RSS News Fields of Scientific Study RSS ... Next Sort By: Page Views Date First Parkinson's Gene Therapy Patient Passes One Year view more ... Polymers are promising tools for gene therapy New methods are being developed to cure illnesses with the aid of gene therapy. Polymer technology provides new and versatile possibilities for administering gene doses. "Polymers are used to pack the gene to be transferred into particles of the size of a ten thousandth of a millimetre. These... view more Gene therapy completely suppresses ovarian cancer growth in animal model University of Pittsburgh School of Medicine researchers have used gene therapy to either completely abolish or significantly inhibit tumor progression in a mouse model of ovarian cancer. view more "Suicide gene" injection shrinks cancer growth Injectable "suicide gene" therapy may be a highly effective way of preventing colon cancer from spreading (metastasising), finds research in Gut. Human colon cancer carries a high risk of death because it is often not found in the early stages and readily spreads to the liver, but also the lungs...

71. Linkedwords.com Web Search - Who.is http//www.thebizplace.com/consumer_goods_services/biotechnology_pharmaceuticals/gene_therapy whois - alexa rank 2127806 http://www.whois.ws/websearch.php?current_name=linkedwords.com

72. Gene Therapy Trial Underway In Fight Against Pancreatic Cancer A team of scientists at the University of Liverpool is running the world s first gene therapy trial to treat patients with pancreatic cancer. http://www.liv.ac.uk/newsroom/press_releases/2004/06/gene_therapy.htm

Skip navigation our city The place to be Liverpool- the city ... Contact us Search University of Liverpool for A-Z index Staff Students Home ... June 2004 press releases > Gene therapy trial underway in fight against pancreatic cancer Newsroom Press releases 2008 Press releases 2007 Find an expert ... Who's who Gene therapy trial underway in fight against pancreatic cancer Liverpool, UK - 2 June 2004: A team of scientists at the University of Liverpool is running the world's first gene therapy trial to treat patients with pancreatic cancer. More than 80% of patients are unsuitable for surgery to remove the cancer and until recently there was little treatment on offer, resulting in a high percentage of deaths within a year of diagnosis. The drug can be injected into the cancer and the gene it contains can then generate the enzyme in the cancer cells. The chemotherapy drug administered is inactive when it enters the bloodstream and is then converted into its active form when it reaches the cancer cells that contain the enzyme. Chemotherapy drugs attack both cancerous and normal cells, which can limit their use. The advantage of MetXia is that the chemotherapy is limited mostly to the tumour cells and is thus more effective at killing the cancer.

73. Gene Therapy The introduction of therapeutically valuable genes into humans using vectors, such as viral vectors, is called gene therapy, a new and rapidly evolving http://www.sigmaaldrich.com/Area_of_Interest/Life_Science/Cell_Culture/Product_L

Life Science Antibodies Automation Cancer Research ... PathFinder GENE THERAPY MEDIA Cell Culture Traditionally, viruses useful as vaccines are propagated in cell culture medium that is supplemented with serum. Today, there is increased recognition and concern that adventitious agents contained in animal-derived raw materials may be introduced into the manufacturing process, and ultimately the drug. Therefore, most regulatory agencies now recommend that manufacturers of therapeutic drugs avoid, to the degree possible, the use of animal-derived materials in their manufacturing process. Product # Product Name Description Application G 9916 Gene Therapy Medium 3 for Adenovirus Production Technical Abstract Performance Data Liquid; Proprietary formulation: Without L-glutamine; supplement with 20 ml of 200mM L-glutamine per liter of medium prior to use. Sterile filtered; Endotoxin tested; Cell culture tested This product is essentially devoid of proteins and free of all animal-derived components. Hence, its use greatly reduces the risks of contamination of gene therapy products with animal-derived biological agents back to top Use of this web site constitutes your acceptance of the Site Use Terms privacy terms and conditions Business Development Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich, Inc. Best viewed in

74. The Biotech Weblog Gene Therapy Filed in archive Diagnostics, Methodologies and Instrumentation , Gene Therapy , Genomics, Proteomics and Bioinformatics , Stem Cells by ruth on February 18 http://www.biotech-weblog.com/50226711/gene_therapy.php

75. Gene-Therapy Deaths Raise Ethics Issues After nearly two decades of research, success is not a word generally associated with gene therapy. It s even led to deaths that some experts believe should http://www.wired.com/medtech/genetics/news/2007/08/gene_therapy

@import "/css/toolbox_article_bottom.css"; @import "/css/article.css"; @import "/css/google_ad.css"; @import "/css/wiredcomment.css"; Subscribe Renew Give a Gift Change Address ... WIRED Science Top Stories Magazine Wired Blogs All Wired Med-Tech Genetics Gene Therapy: Is Death an Acceptable Risk? By Brandon Keim Jolee Mohr, 36, died during a clinical trial using gene therapy to treat rheumatoid arthritis. The photograph was taken on July 1, the day before she received the injection. Photo: Courtesy of the Mohr family A 36-year-old woman with rheumatoid arthritis died in July, while participating in a gene-therapy clinical trial. Some experts say she shouldn't have received such an unpredictable, potentially dangerous treatment in the first place. Jolee Mohr was married, the mother of a 5-year-old daughter, and worked at the Secretary of State's office in her hometown of Springfield, Illinois. By all accounts she was able to lead a full and active life, with existing drugs keeping her disease under control. The Food and Drug Administration and the National Institutes of Health are still studying whether the trial therapy played a role in Mohr's death . But a sudden infection raged through her body and caused her organs to fail just after the experimental treatment was injected into her right knee, which has raised suspicion that her death was linked to the therapy.

76. "Genetically Modified (GM) Baculovirus Vectors To Control Insect Pests And For G Genetically Modified (GM) Baculovirus Vectors to Control Insect Pests and for Gene Therapy . Joe Cummins. Baculovirus are virus that infect insects, http://www.biotech-info.net/gene_therapy.html

"Genetically Modified (GM) Baculovirus Vectors to Control Insect Pests and for Gene Therapy" Joe Cummins Baculovirus are virus that infect insects, they are very stable and may remain dormant in the environment for years before infecting insects. The virus can be purified and produced in quantity to be used in insect control. Since the virus multiplies and persists its use in pest control seems promising. The virus alone has a relatively low killing power and slow action. When a gene for a potent toxin such as scorpion toxin or a gene effecting a juvenile hormone is added to the virus it kills faster and fewer insects survive infection. Numerous field tests of modified virus sprayed on crops have been undertaken often accompanied by loud expressions of concern from the public. Soon after GM virus were developed for insect control it was found that baculovirus were capable of infecting human liver cells and produced relatively little toxicity to the infected cells. For that reason baculovirus vectors were developed to treat liver disease. The mode of virus replication seems to make the recombinant virus highly unpredictable and prone to generating potentially undesirable variants. This important finding has not yet influenced the risk analysis of recombinant baculovirus insecticides and gene therapy vectors.

77. Gene Therapy News For more information on GTBN click on the title above or to the left. Copyright © 2004, 2005, 2006 DataTrends Publications, Inc. http://www.datatrendspublications.com/Gene_Therapy.htm

DataTrends publishes one biweekly newsletter in the gene therapy field: Gene Therapy Research News For more information on GTBN click on the title above or to the left.

78. Gene Therapy Skip Navigation. Health System Calendars Maps AZ Index UVa. HS Web, People. General Clinical Research Center Enrolling Studies Seeking Volunteers http://www.healthsystem.virginia.edu/internet/gcrc/PI/Gene_Therapy.cfm

University of Virginia Health System Skip Navigation Health System Calendars ... UVa HS Web People General Clinical Research Center Enrolling Studies Seeking Volunteers Submit a Protocol ... Outlook eMail Search this Site Keywords or Phrases View the Site Index Human Gene Therapy Trials on the GCRC Clinical research with genetic material poses many safety and methodologic challenges not shared by other forms of human investigation. As a result, there are a number of regulatory requirements that must be satisfied before any human studies involving gene transfer can be initiated. Presented below are guidelines to assist the clinical investigator in opening a gene therapy study on the GCRC. The policy of the GCRC is to require that a gene therapy protocol be approved by all committees/agencies listed below before the first patient can be enrolled. Investigators may choose to submit a proposal to the National Gene Vector Laboratories (NGVL) for clinical grade vector for use in their clinical trials. REGULATORY REQUIREMENTS Clinical protocols that involve the administration of recombinant DNA products into human subjects must be approved by the following reviewing bodies: FEDERAL REQUIREMENTS: Food and Drug Administration (FDA) http://www.fda.gov/cber/

79. Salon.com Health | Gene Therapy R.I.P.? Health Body Mothers Who Think News People Politics Sex Technology Travel Food . Article Finder, Health http://archive.salon.com/health/feature/2000/06/01/gene_therapy/

Apache::Oas::ad('TopLeft') Apache::Oas::ad('Top') Apache::Oas::ad('TopRight') Search About Salon Table Talk Newsletters ... Search Articles by date All of Salon.com Books Business Comics ... Table Talk [Freewheeling Salon forums] On pins and needles? Maybe acupuncture is the answer. Tame your tummy! Which exercises are best for flatter abs? Living mementos Our scars are one-of-a-kind souvenirs. Posts of the week The Well [Pioneering members-only discussions] Geaux Opelousas! A former Berkeleyite takes on a new lifestyle in Louisiana. Sound Off E-mail Salon Send us a Letter to the Editor Today's letters Newsletter Sign up to receive free e-mail updates from Salon now in 12 different varieties! Downloads Get Salon.com on your PDA Salon.com headlines from More ways to get Salon Gene therapy R.I.P.? When the country's biggest gene therapy institute was ordered to stop testing on humans last week, the action marked the end of an era fraught with dubious claims to success and a mess of unreported adverse effects. By Tabitha M. Powledge In September, Jesse Gelsinger, a teenage patient undergoing experimental gene therapy for a rare genetic disorder, died at the Institute for Human Gene Therapy at the University of Pennsylvania. People die during experimental treatments all the time because they are usually terribly sick. But Jesse was not particularly ill, and his father says the researchers played up the potential benefits of the study and played down the potential risks. The researchers deny this, so Jesse's father is talking about filing suit.

80. Cornell News: Night-blind Gene Therapy Scientists at Cornell, the University of Pennsylvania and the University of Florida, Gainesville have used gene therapy to restore vision in dogs blinded by http://www.news.cornell.edu/releases/April01/gene_therapy.hrs.html

Gene therapy restores vision to dogs blinded by inherited disease, bringing new hope to childhood sufferers of similar condition EMBARGOED FOR RELEASE: FRIDAY, APRIL 27, 2001, AT 5 P.M. EST Contact: Roger Segelken Office: 607-255-9736 E-Mail: hrs2@cornell.edu A retinal fundus photograph of a Briard dog with the inherited eye disease, congenital stationary night blindness. Mutations to the same gene in humans, RPE65, cause Leber congenital amaurosis, beginning in childhood. But gene-therapy experiments in Briards hold hope for curing the disease in humans. Credit: G. Aguirre/Cornell University., A high-resolution copy of this photo (2592 x 3704 pixels, 448K) is available here ITHACA, N.Y. Dogs blinded by an inherited retinal degenerative disease had their vision restored after treatment with genes from healthy dogs, marking the first successful gene therapy for blindness in a large animal. The treatment offers hope for humans with a similar condition. The achievement, with young dogs suffering from congenital stationary night blindness, which is similar to a childhood disease called Leber congenital amaurosis, is reported in the May 2001 issue of the journal Nature Genetics by Gregory M. Acland, Gustavo D. Aguirre, Jharna Ray, Qi Zhang and Susan E. Pearce-Kelling, all at the Cornell University College of Veterinary Medicine; by Tomas S. Aleman, Artur V. Cideciyan, Vibha Anand, Yong Zeng, Albert M. Maguire, Samuel G. Jacobson and Jean Bennett, all at the University of Pennsylvania; and by William W. Hauswirth of the University of Florida, Gainesville.

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 4     61-80 of 83    Back | 1  | 2  | 3  | 4  | 5  | Next 20